Metformin therapy and prostate cancer risk: a meta-analysis of observational studies.
about
Metformin therapy and risk of colorectal adenomas and colorectal cancer in type 2 diabetes mellitus patients: A systematic review and meta-analysisMetformin: A Bridge between Diabetes and Prostate Cancer.Metformin, Asian ethnicity and risk of prostate cancer in type 2 diabetes: a systematic review and meta-analysis.A systematic review of the literature exploring the interplay between prostate cancer and type two diabetes mellitus.Valproic acid sensitizes metformin-resistant human renal cell carcinoma cells by upregulating H3 acetylation and EMT reversal.
P2860
Metformin therapy and prostate cancer risk: a meta-analysis of observational studies.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Metformin therapy and prostate cancer risk: a meta-analysis of observational studies.
@ast
Metformin therapy and prostate cancer risk: a meta-analysis of observational studies.
@en
type
label
Metformin therapy and prostate cancer risk: a meta-analysis of observational studies.
@ast
Metformin therapy and prostate cancer risk: a meta-analysis of observational studies.
@en
prefLabel
Metformin therapy and prostate cancer risk: a meta-analysis of observational studies.
@ast
Metformin therapy and prostate cancer risk: a meta-analysis of observational studies.
@en
P2093
P2860
P1476
Metformin therapy and prostate cancer risk: a meta-analysis of observational studies.
@en
P2093
Gang-Feng Wu
Guan-Fu Zhang
Jia-Jun Yan
Jian-Gang Pan
Shou-Hua Pan
Xiang-Rong Ying
Xiao-Long Zhang
Zhen-Gang Luo
P2860
P304
13089-13098
P577
2015-08-15T00:00:00Z